GSK 4112antagonist of the Nuclear Heme Receptor REV-ERB CAS# 1216744-19-2 |
Package In Stock
Quality Control & MSDS
Chemical structure
3D structure
Number of papers citing our products
Cas No. | 1216744-19-2 | SDF | Download SDF |
PubChem ID | 50905018 | Appearance | Powder |
Formula | C18H21ClN2O4S | M.Wt | 396.89 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | SR 6452 | ||
Solubility | Soluble to 25 mM in DMSO | ||
Chemical Name | tert-butyl 2-[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]acetate | ||
SMILES | CC(C)(C)OC(=O)CN(CC1=CC=C(C=C1)Cl)CC2=CC=C(S2)[N+](=O)[O-] | ||
Standard InChIKey | WYSLOKHVFKLWOU-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C18H21ClN2O4S/c1-18(2,3)25-17(22)12-20(10-13-4-6-14(19)7-5-13)11-15-8-9-16(26-15)21(23)24/h4-9H,10-12H2,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Selective Rev-Erbα agonist (EC50 = 250 nM). Enhances recruitment of nuclear receptor co-repressor (NCoR) peptide to Rev-Erbα; causes acute suppression of Bmal1 gene transcription. Induces phase shifts in the circadian clock. |
GSK 4112 Dilution Calculator
GSK 4112 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.5196 mL | 12.5979 mL | 25.1959 mL | 50.3918 mL | 62.9897 mL |
5 mM | 0.5039 mL | 2.5196 mL | 5.0392 mL | 10.0784 mL | 12.5979 mL |
10 mM | 0.252 mL | 1.2598 mL | 2.5196 mL | 5.0392 mL | 6.299 mL |
50 mM | 0.0504 mL | 0.252 mL | 0.5039 mL | 1.0078 mL | 1.2598 mL |
100 mM | 0.0252 mL | 0.126 mL | 0.252 mL | 0.5039 mL | 0.6299 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
IC50: 2.3 μM
GSK4112 is a synthetic antagonist of the Nuclear Heme Receptor REV-ERB.
Rev-erbα and Rev-erbβ are heme sensors and atypical members of the nuclear receptor superfamily. As a member of the nuclear receptor superfamily, REV-ERBR functions as a receptor for the porphoryin heme. REV-ERBR can suppress the transcription of its target genes in a heme-dependent manner.
In vitro: Previous study showed that GSK4112 addition to either the REV-ERBR or REV-ERBβ assay led to enhanced repression. Cells were treated the with GSK4112 and similar pattern in GAL4 chimeric receptor assay was observed. In addition, GSK4112 suppressed reporter gene expression. GSK4112 also suppressed transcription driven by the Bmal1 promoter dose-dependently. GSK4112 activity was found to be associated with REV-ERBR [1].
In vivo: GSK4112 was found to display poor pharmacokinetic properties (rat liver microsomal Cint > 1.0 mL/min/mg protein; lack of oral bioavailability (F < 1% in mice)), which likely limited its use to biochemical and cell-based assays. As a result, GSK4112 was unlikely to be suitable for in vivo studies [1].
Clinical trial: N/A
Reference:
[1] Daniel Grant,Lei Yin,Jon L. Collins et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear Heme receptor Rev-erbα. ACS CHEMICAL BIOLOGY5(10):925-32.
- BYK 191023 dihydrochloride
Catalog No.:BCC7506
CAS No.:1216722-25-6
- SCH 79797 dihydrochloride
Catalog No.:BCC7125
CAS No.:1216720-69-2
- Trap 101
Catalog No.:BCC7390
CAS No.:1216621-00-9
- 2-Cyclopropyl-4-(4-fluorophenyl)quinoline-3-carboxaldehyde
Catalog No.:BCC8573
CAS No.:121660-37-5
- 2-Cyclopropyl-4-(4-fluorophenyl)-quinolyl-3-methanol
Catalog No.:BCC8574
CAS No.:121660-11-5
- ZK 93423 hydrochloride
Catalog No.:BCC7227
CAS No.:1216574-52-5
- BX 513 hydrochloride
Catalog No.:BCC5940
CAS No.:1216540-18-9
- Kaempferol-3-O-(2',6'-di-O-trans-p-coumaroyl)-beta-D-glucopyranoside
Catalog No.:BCN1603
CAS No.:121651-61-4
- SB 258585 hydrochloride
Catalog No.:BCC7216
CAS No.:1216468-02-8
- YM 298198 hydrochloride
Catalog No.:BCC7366
CAS No.:1216398-09-2
- 6-Demethoxycleomiscosin A
Catalog No.:BCN7299
CAS No.:121587-20-0
- 6-Demethoxy-9'-deoxycleomiscosin A
Catalog No.:BCN7298
CAS No.:121587-18-6
- ZK 93426 hydrochloride
Catalog No.:BCC7229
CAS No.:1216792-30-1
- CGP 20712 dihydrochloride
Catalog No.:BCC6893
CAS No.:1216905-73-5
- Sarafotoxin S6c
Catalog No.:BCC5721
CAS No.:121695-87-2
- Moluccanin
Catalog No.:BCN6107
CAS No.:121700-26-3
- Moluccanin diacetate
Catalog No.:BCN6108
CAS No.:121700-27-4
- PTC209 HBr
Catalog No.:BCC5640
CAS No.:1217022-63-3
- BU 239 hydrochloride
Catalog No.:BCC5668
CAS No.:1217041-98-9
- GYKI 47261 dihydrochloride
Catalog No.:BCC7566
CAS No.:1217049-32-5
- 6-O-p-Methoxycinnamoylcatalpol
Catalog No.:BCN6109
CAS No.:121710-02-9
- CP 31398 dihydrochloride
Catalog No.:BCC2406
CAS No.:1217195-61-3
- A 350619 hydrochloride
Catalog No.:BCC5939
CAS No.:1217201-17-6
- VD2-D3
Catalog No.:BCC2034
CAS No.:1217448-46-8
The nuclear receptor and clock gene REV-ERBalpha regulates cigarette smoke-induced lung inflammation.[Pubmed:28974420]
Biochem Biophys Res Commun. 2017 Dec 2;493(4):1390-1395.
REV-ERBalpha is a nuclear heme receptor, transcriptional repressor and critical component of the molecular clock that drives daily rhythms of metabolism. Evidence reveals that REV-ERBalpha also plays an important regulatory role in clock-dependent lung physiology and inflammatory responses. We hypothesize that cigarette smoke (CS) exposure influences REV-ERBalpha abundance in the lungs, facilitating a pro-inflammatory phenotype. To determine the impact of REV-ERBalpha activation in the CS-induced inflammatory response we treated primary human small airway epithelial cells (SAECs) with CS extract (CSE) or lipopolysaccharide (LPS) in the absence or presence of pre-treatment with the REV-ERBalpha agonist GSK 4112. We also exposed adult C57BL/6J (WT) and Rev-erbalpha global KO mice to CS (10 and 30 days) and measured pro-inflammatory cytokine release. Our data reveal that pre-treatment with GSK 4112 reduced CSE/LPS induced pro-inflammatory cytokines release from both SAECs and mouse lung fibroblasts (MLFs). Furthermore, REV-ERBalpha KO mice show a greater inflammatory response to 10 and 30 days of CS, including increased neutrophil lung influx, pro-inflammatory cytokine (IL-6, MCP-1 and KC) release, and pro-senescence marker (p16) when compared to WT mice. These data demonstrate that REV-ERBalpha is a critical regulator of CS-induced lung inflammatory responses.
Identification of SR8278, a synthetic antagonist of the nuclear heme receptor REV-ERB.[Pubmed:21043485]
ACS Chem Biol. 2011 Feb 18;6(2):131-4.
REV-ERBalpha is a member of the nuclear receptor superfamily that functions as a receptor for the porphoryin heme. REV-ERBalpha suppresses transcription of its target genes in a heme-dependent manner. Recently, the first nonporphyrin synthetic ligand for REV-ERBalpha, GSK4112, was designed, and it mimics the action of heme acting as agonist. Here, we report the identification of the first REV-ERB antagonist, SR8278. SR8278 is structurally similar to the agonist but blocks the ability of the GSK4112 to enhance REV-ERBalpha-dependent repression in a cotransfection assay. Additionally, whereas GSK4112 suppresses the expression of REV-ERBalpha target genes involved in gluconeogenesis, SR8278 stimulates the expression of these genes. Thus, SR8278 represents a unique chemical tool for probing REV-ERB function and may serve as a point for initiation of further optimization to develop REV-ERB antagonists with the ability to explore circadian and metabolic functions.